Spin-off news
Here you can find news from MPG spin-off companies.
MorphoSys
MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL
Evotec
Evotec receives € 3 m milestone payment for Bayer starting Phase II clinical development of DNP programme
Alnylam
Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for OXLUMO® for the Treatment of Advanced Primary Hyperoxaluria Type 1